Literature DB >> 30284495

Graphene oxide-chloroquine nanoconjugate induce necroptotic death in A549 cancer cells through autophagy modulation.

Braham D Arya1,2, Sandeep Mittal2,3, Prachi Joshi1, Alok K Pandey2,3, Jaime E Ramirez-Vick4, Surinder P Singh1,2.   

Abstract

AIM: Chloroquine (Chl) has shown its potential in cancer therapy and graphene oxide (GO) exhibited excellent tumor-targeting ability, biocompatibility and low toxicity. We have endeavored to conjugate Chl to GO sheets and investigated the nonproliferation action on A549 cell lines along with cell signaling pathways. MATERIALS &
METHODS: Cellular toxicity, autophagic flux modulation and cell death mechanism induced by GO-Chl have been investigated on A549 cell lines. RESULTS &
CONCLUSION: GO-Chl induces accumulation of autophagosomes (monodansylcadaverine staining, green fluorescence protein-tagged LC3 plasmid and transmission electron microscopy observations) in A549 cells through the blockade of autophagic flux that serves as scaffold for necrosome assembling and activates necroptotic cell death. GO-Chl nanoconjugate could be used as an effective cancer therapeutic agent, by targeting the autophagy necroptosis axis.

Entities:  

Keywords:  A549; autophagosomes; autophagy; cancer therapy; chloroquine; endocytosis; graphene oxide; lysosome; nanoconjugate; necroptosis

Mesh:

Substances:

Year:  2018        PMID: 30284495     DOI: 10.2217/nnm-2018-0086

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  12 in total

Review 1.  Autophagy and cancer treatment: four functional forms of autophagy and their therapeutic applications.

Authors:  Zhaoshi Bai; Yaling Peng; Xinyue Ye; Zhixian Liu; Yupeng Li; Lingman Ma
Journal:  J Zhejiang Univ Sci B       Date:  2022-02-15       Impact factor: 3.066

Review 2.  Cell Death and the p53 Enigma During Mammalian Embryonic Development.

Authors:  Sonam Raj; Sushil K Jaiswal; Melvin L DePamphilis
Journal:  Stem Cells       Date:  2022-03-31       Impact factor: 5.845

Review 3.  Nanotherapeutics in autophagy: a paradigm shift in cancer treatment.

Authors:  Shloka Negi; Aiswarya Chaudhuri; Dulla Naveen Kumar; Deepa Dehari; Sanjay Singh; Ashish Kumar Agrawal
Journal:  Drug Deliv Transl Res       Date:  2022-02-11       Impact factor: 5.671

Review 4.  The interplay of autophagy and non-apoptotic cell death pathways.

Authors:  Dannah R Miller; Scott D Cramer; Andrew Thorburn
Journal:  Int Rev Cell Mol Biol       Date:  2020-01-13       Impact factor: 6.813

5.  Graphene oxide regulates endoplasmic reticulum stress: autophagic pathways in nasopharyngeal carcinoma cells.

Authors:  Huan Xiao; Xia Yang; Li-Hui Luo; Zong Ning
Journal:  Int J Clin Exp Pathol       Date:  2018-12-01

6.  MiR-369-3p participates in endometrioid adenocarcinoma via the regulation of autophagy.

Authors:  Ping Liu; Chengbin Ma; Qiongwei Wu; Wenying Zhang; Cao Wang; Li Yuan; Xiaowei Xi
Journal:  Cancer Cell Int       Date:  2019-07-11       Impact factor: 5.722

Review 7.  Nanomaterial-mediated autophagy: coexisting hazard and health benefits in biomedicine.

Authors:  Xiaoli Feng; Yaqing Zhang; Chao Zhang; Xuan Lai; Yanli Zhang; Junrong Wu; Chen Hu; Longquan Shao
Journal:  Part Fibre Toxicol       Date:  2020-10-16       Impact factor: 9.400

Review 8.  Ferroptosis, necroptosis, and pyroptosis in anticancer immunity.

Authors:  Rong Tang; Jin Xu; Bo Zhang; Jiang Liu; Chen Liang; Jie Hua; Qingcai Meng; Xianjun Yu; Si Shi
Journal:  J Hematol Oncol       Date:  2020-08-10       Impact factor: 17.388

9.  PEG-Ceramide Nanomicelles Induce Autophagy and Degrade Tau Proteins in N2a Cells.

Authors:  Jie Gao; Xiaohan Chen; Tianjun Ma; Bin He; Peng Li; Yucheng Zhao; Yuejin Ma; Jianhua Zhuang; You Yin
Journal:  Int J Nanomedicine       Date:  2020-09-11

10.  Genomic variations and signatures of selection in Wuhua yellow chicken.

Authors:  Zhuoxian Weng; Yongjie Xu; Weina Li; Jiebo Chen; Ming Zhong; Fusheng Zhong; Bingwang Du; Bin Zhang; Xunhe Huang
Journal:  PLoS One       Date:  2020-10-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.